A role for nuclear translocation of tripeptidyl-peptidase II in reactive oxygen species-dependent DNA damage responses

Biochemical and Biophysical Research Communications

Volumn 389, Issue 4, 2009, Pages 575-579

  Preta, Giulio ^a   de Klark, Rainier ^a   Glas, Rickard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; DNA damage; p53; ROS; Tripeptidyl peptidase II

Indexed keywords

ACETYLCYSTEINE; PEPTIDASE; REACTIVE OXYGEN METABOLITE; ROTENONE; TRIPEPTIDYL PEPTIDASE II; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; COLON CARCINOMA; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; IMMUNOCYTOCHEMISTRY; MELANOMA; NONHUMAN; PRIORITY JOURNAL; SARCOMA;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; DNA DAMAGE; GAMMA RAYS; HUMANS; MICE; REACTIVE OXYGEN SPECIES; SERINE ENDOPEPTIDASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349754674     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.021     Document Type: Article

References (33)

1. Bakkenist C.J., and Kastan M.B. Initiating cellular stress responses. Cell 118 (2004) 9-17
2. Matsuoka S., A Ballif B., Smogorzewska A., McDonald III E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., and Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
3. Raha S., and Robinson B.H. Mitochondria, oxygen free radicals, and apoptosis. Am. J. Med. Genet. 106 (2001) 62-70
4. Kurz E.U., Douglas P., and Lees-Miller S.P. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J. Biol. Chem. 279 (2004) 53272-53281
5. Karawajew L., Rhein P., Czerwony G., and Ludwig W.D. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood 105 (2005) 4767-4775
6. Burhans W.C., and Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 35 (2007) 7545-7556
7. Dröge W., and Schipper H.M. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6 (2007) 361-370
8. Fruehauf J.P., and Trapp V. Reactive oxygen species: an Achilles' heel of melanoma?. Expert Rev. Anticancer Ther. 8 (2008) 1751-1757
9. Chen S., Zhao Y., Zhao G., Han W., Bao L., Yu K.N., and Wu L. Up-regulation of ROS by mitochondria-dependent bystander signaling contributes to genotoxicity of bystander effects. Mutat. Res. 666 (2009) 68-73
10. Hong X., Lei L., Künert B., Naredla R., Applequist S.E., Grandien A., and Glas R. Tripeptidyl-peptidase II controls DNA damage responses and in vivo gamma-irradiation resistance of tumors. Cancer Res. 67 (2007) 7165-7174
11. Firat E., Tsurumi C., Gaedicke S., Huai J., and Niedermann G. Tripeptidyl peptidase II plays a role in the radiation response of selected primary cell types but not based on nuclear translocation and p53 stabilization. Cancer Res. 69 (2009) 3325-3331
12. Tsurumi C., Firat E., Gaedicke S., Huai J., Mandal P.K., and Niedermann G. Viability and DNA damage responses of TPPII-deficient Myc- and Ras-transformed fibroblasts. Biochem. Biophys. Res. Commun. 386 (2009) 563-568
13. Rockel B., Peters J., Kühlmorgen B., Glaeser R.M., and Baumeister W. A giant protease with a twist: the TPP II complex from Drosophila studied by electron microscopy. EMBO J. 21 (2009) 5979-5984
14. Eriksson S., Guitérrez O.A., Bjerling P., and Tomkinson B. Development, evaluation and application of tripeptidyl-peptidase II sequence signatures. Arch. Biochem. Biophys. 484 (2009) 39-45
15. Renn S.C., Tomkinson B., and Taghert P.H. Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster. J. Biol. Chem. 273 (1998) 19173-19182
16. Glas R., Bogyo M., McMaster J.S., Gaczynska M., and Ploegh H.L. A proteolytic system that compensates for loss of proteasome function. Nature 392 (1998) 618-622
17. Geier E., Pfeifer G., Wilm M., Lucchiari-Hartz M., Baumeister W., Eichmann K., and Niedermann G. A giant protease with potential to substitute for some functions of the proteasome. Science 283 (1999) 978-981
18. Gavioli R., Frisan T., Vertuani S., Bornkamm G.W., and Masucci M.G. C-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat. Cell Biol. 3 (2001) 283-288
19. Seifert U., Marañón C., Shmueli A., Desoutter J.F., Wesoloski L., Janek K., Henklein P., Diescher S., Andrieu M., De la Salle H., Weinschenk T., Schild H., Laderach D., Galy A., Haas G., Kloetzel P.M., Reiss Y., and Hosmalin A. Nat. Immunol. 4 (2003) 375-379
20. Reits E., Neijssen J., Herberts C., Benckhuijsen W., Janssen L., Drijfhout J.W., and Neefjes J. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20 (2004) 495-506
21. York I.A., Bhutani N., Zendzian S., Goldberg A.L., and Rock K.L. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation. J. Immunol. 177 (2006) 1434-1443
22. Firat E., Huai J., Saveanu L., Gaedicke S., Aichele P., Eichmann K., Van Endert P., and Niedermann G. Analysis of direct and cross-presentation of antigens in TPPII knockout mice. J. Immunol. 179 (2007) 8137-8145
23. Huai J., Firat E., Nil A., Million D., Gaedicke S., Kanzler B., Freudenberg M., Van Endert P., Kohler G., Pahl H.L., Aichele P., Eichmann K., and Niedermann G. Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice. Proc. Natl. Acad. Sci. USA 105 (2008) 5177-5182
24. McKay R.M., McKay J.P., Suh J.M., Avery L., and Graff J.M. Tripeptidyl peptidase II promotes fat formation in a conserved fashion. EMBO Rep. 8 (2007) 1183-1189
25. Rose C., Vargas F., Facchinetti P., Bourgeat P., Bambal R.B., Bishop P.B., Chan S.M., Moore A.N., Ganellin C.R., and Schwartz J.C. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature 380 (1996) 403-409
26. Lindås A.C., Eriksson S., Jozsa E., and Tomkinson B. Investigation of a role for Glu-331 and Glu-305 in substrate binding of tripeptidyl-peptidase II. Biochim. Biophys. Acta 1784 (2008) 1899-1907
27. Frappart P.O., and McKinnon P.J. Ataxia-telangiectasia and related diseases. Neuromol. Med. 8 (2006) 495-511
28. Bartkova J., Horejsí Z., Koed K., Krämer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Ørntoft T., Lukas J., and Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
29. Bartkova J., Horejsí Z., Sehested M., Nesland J.M., Rajpert-De Meyts E., Skakkebaek N.E., Stucki M., Jackson S., Lukas J., and Bartek J. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene 26 (2007) 7414-7422
30. Amaravadi R.K., and Thompson C.B. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 13 (2007) 7271-7279
31. Gudkov A.V., and Komarova E.A. The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer 3 (2003) 117-129
32. Mirshafiey A., and Mohsenzadegan M. Antioxidant therapy in multiple sclerosis. Immunopharmacol. Immunotoxicol. 31 (2009) 13-29
33. Sasaki M., Ikeda H., and Nakanuma Y. Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study. J. Autoimmun. 31 (2008) 73-78